Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/28/2007
 
First Published:
10/1/2002
1.
Phase IV Randomized Study of Epoetin beta for Anemia Management in Patients With Stage IIB, III, or IVA Cervical Cancer Treated With Cisplatin and Radiotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Completed
Over 18
Pharmaceutical / Industry
AGOSG-OVAR-MO16375-MARCH
EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969
2.
A Study of the Management of Blood Loss in Patients Undergoing Surgical Removal of Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Completed
18 and over
Pharmaceutical / Industry
CR003460
NCT00264095
3.
Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
20 to 79
Pharmaceutical / Industry
EPO316 JP
NCT00628043
4.
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
61 to 75
Other
BACOPP-21
NCT00284271
Last Modified:
10/22/2008
 
First Published:
11/14/2007
5.
Phase II Study of Epoetin beta for Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Closed
18 and over
Other
CHUL-NEOPALIA
RECF0359, NEOPALIA, NCT00559195
6.
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
ML20559
NCT00551291
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute